Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan units
US10364425B2 · kind B2 · utility
2Cited by
17References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 2013 |
| Grant date | Jul 30, 2019 |
| Priority date | — |
| Expiry date | May 2, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is related to a composition of recombinant or transgenic Factor VII, each molecule of Factor VII of the composition exhibiting two N-glycosylation sites, wherein, among all the molecules of FVII of the composition, the rate of Galα1,3G al glycan moieties is comprised between 0 and 4%. The invention is also related to a process for preparing such a composition of FVII.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.